Cargando…

Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease

AIMS: Epidemiological evidence for the link of interleukin 1 (IL-1) and its inhibition with cardiovascular diseases (CVDs) remains controversial. We aim to investigate the cardiovascular effects of IL-1 receptor antagonist (IL-1Ra) and underlying mechanisms. METHODS: Genetic variants identified from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fangkun, Huangfu, Ning, Shen, Jiaxi, Su, Pengpeng, Zhu, Lujie, Cui, Hanbin, Yuan, Shuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628700/ https://www.ncbi.nlm.nih.gov/pubmed/37941911 http://dx.doi.org/10.3389/fendo.2023.1278273

Ejemplares similares

Causal association between sleep traits and the risk of coronary artery disease in patients with diabetes
por: Tian, Mengyun, et al.
Publicado: (2023)

Genetic liability to mental disorders in relation to the risk of hypertension
por: Huangfu, Ning, et al.
Publicado: (2023)

Dissecting the Association of Apolipoprotein E Gene Polymorphisms With Type 2 Diabetes Mellitus and Coronary Artery Disease
por: Wu, Lei, et al.
Publicado: (2022)

Increased selenium and decreased iron levels in relation to risk of coronary artery disease in patients with diabetes
por: Tian, Mengyun, et al.
Publicado: (2023)

Proteomic insights into the associations between obesity, lifestyle factors, and coronary artery disease
por: Yang, Fangkun, et al.
Publicado: (2023)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
por: Baldassano, Sara, et al.
Publicado: (2019)

ACTH Antagonists
por: Clark, Adrian John, et al.
Publicado: (2016)

The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease
por: Ou-Yang, Wen-Lu, et al.
Publicado: (2021)

Meal-Related Changes in Apolipoprotein Particles After Treatment With an Antisense Oligonucleotide to Apolipoprotein CIII
por: Brite, Brianna, et al.
Publicado: (2021)

Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
por: Guan, Yunpeng, et al.
Publicado: (2021)

The association of apolipoprotein B with chronic kidney disease in the Chinese population
por: Xu, Yu, et al.
Publicado: (2023)

Brain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrP(C)), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum differentiate urban children exposed to severe vs. low air pollution
por: Calderón-Garcidueñas, Lilian, et al.
Publicado: (2013)

The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice
por: Ku, Eu Jeong, et al.
Publicado: (2022)

Low Intelligence Predicts Higher Risks of Coronary Artery Disease and Myocardial Infarction: Evidence From Mendelian Randomization Study
por: Yang, Fangkun, et al.
Publicado: (2022)

LBODP028 Identifying Biomarkers For Predicting Response To Mineralocorticoid Receptor Antagonist Treatment In Heart Failure
por: Karthigan, Nikshay, et al.
Publicado: (2022)

Apolipoprotein M—A Marker or an Active Player in Type II Diabetes?
por: Christoffersen, Christina
Publicado: (2021)

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
por: Anderson, Ross C., et al.
Publicado: (2019)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021)

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis
por: Zhang, Hui, et al.
Publicado: (2021)

AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists
por: Moody, Terry W., et al.
Publicado: (2017)

LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity
por: Lu, Xuehan, et al.
Publicado: (2021)

A prediction model for high ovarian response in the GnRH antagonist protocol
por: Jiang, Yilin, et al.
Publicado: (2023)

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease
por: Yu, Lu, et al.
Publicado: (2022)

Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus
por: Zhang, Xinxin, et al.
Publicado: (2022)

Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
por: Zhang, Xinyuan, et al.
Publicado: (2022)

Comparison of prognosis after partial and total surgical resection for parathyroid carcinoma: an inverse probability of treatment weighting analysis of the SEER database
por: Jin, Shuai, et al.
Publicado: (2023)

Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults
por: Zheng, Shuang, et al.
Publicado: (2017)

LH Levels May Be Used as an Indicator for the Time of Antagonist Administration in GnRH Antagonist Protocols—A Proof-Of-Concept Study
por: Liu, Minghui, et al.
Publicado: (2019)

Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
por: Mendivil, Carlos O., et al.
Publicado: (2013)

The relationship between polycystic ovary syndrome and coronary heart disease: a bibliometric analysis
por: Liang, Xuzhi, et al.
Publicado: (2023)

Review of mendelian randomization studies on age at natural menopause
por: Zhang, Xiao, et al.
Publicado: (2023)

From Bioinactive ACTH to ACTH Antagonist: The Clinical Perspective
por: Ghaddhab, Chiraz, et al.
Publicado: (2017)

Histamine H1 receptor antagonist attenuates catecholamine surge and organ injury after severe burns
por: Wang, Jizhuang, et al.
Publicado: (2023)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
por: Lin, Yahui, et al.
Publicado: (2022)

The Apolipoprotein E Antagonistic Pleiotropy Hypothesis: Review and Recommendations
por: Tuminello, Elizabeth R., et al.
Publicado: (2011)

Differentially Regulated Apolipoproteins and Lipid Profiles as Novel Biomarkers for Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration
por: Zhang, Xinyuan, et al.
Publicado: (2022)

Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease
por: Clarke, Robert, et al.
Publicado: (2023)

Leptin receptor antagonist attenuates experimental autoimmune thyroiditis in mice by regulating Treg/Th17 cell differentiation
por: Wang, Wei, et al.
Publicado: (2022)

Editorial: Update on the Endocrinology of Myocardial Aging/Heart Failure
por: Yang, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0oecojqnatuc77vrgpg5f24rnh